Related references
Note: Only part of the references are listed.Serum Level of Lactate Dehydrogenase is Associated with Cardiovascular Disease Risk as Determined by the Framingham Risk Score and Arterial Stiffness in a Health-Examined Population in China
Wenfang Zhu et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)
The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study
Matina Kouvari et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
The association between elevated body mass index and wide blood chemistry panel results in apparently healthy individuals
Tomer Ziv-Baran et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2022)
Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium
Christoph Sinning et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: an 11-year follow-up
Anxin Wang et al.
CARDIOVASCULAR DIABETOLOGY (2021)
A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases
Lars Lind et al.
SCIENTIFIC REPORTS (2021)
Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants
Ziyi Zhou et al.
DIABETOLOGIA (2021)
Association between serum low-density lipoprotein cholesterol and metabolic syndrome in a working population
Saibin Wang
LIPIDS IN HEALTH AND DISEASE (2021)
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021 (vol 44, pg S15, 2021)
E. K. Sims et al.
DIABETES CARE (2021)
High Blood Pressure and Cardiovascular Disease
Flavio D. Fuchs et al.
HYPERTENSION (2020)
Bilirubin in metabolic syndrome and associated inflammatory diseases: New perspectives
Petr Novak et al.
LIFE SCIENCES (2020)
Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort
Maria J. Guembe et al.
CARDIOVASCULAR DIABETOLOGY (2020)
ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation
Daniel Q. Huang et al.
HEPATOLOGY COMMUNICATIONS (2020)
Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status A Nationwide Population-Based Study of Approximately 10 Million Persons
Sehoon Park et al.
ANNALS OF INTERNAL MEDICINE (2019)
Increase of body mass index and waist circumference predicts development of metabolic syndrome criteria in apparently healthy individuals with 2 and 5 years follow-up
Eyal Fisher et al.
INTERNATIONAL JOURNAL OF OBESITY (2019)
Impact of Longitudinal Changes in Metabolic Syndrome Status over 2 Years on 10-Year Incident Diabetes Mellitus
Ji Hye Huh et al.
DIABETES & METABOLISM JOURNAL (2019)
The Global Epidemic of the Metabolic Syndrome
Mohammad G. Saklayen
CURRENT HYPERTENSION REPORTS (2018)
Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study
Nathalie Eckel et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988-2012
Justin Xavier Moore et al.
PREVENTING CHRONIC DISEASE (2017)
Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis
Yunwei Li et al.
ATHEROSCLEROSIS (2017)
Small-dense LDL/large-buoyant LDL ratio associates with the metabolic syndrome
Pornpen Srisawasdi et al.
CLINICAL BIOCHEMISTRY (2015)
Metabolic Health Is a More Important Determinant for Diabetes Development than Simple Obesity: A 4-Year Retrospective Longitudinal Study
Eun-Jung Rhee et al.
PLOS ONE (2014)
Metabolic inflammation: Connecting obesity and insulin resistance
Nassim Dali-Youcef et al.
ANNALS OF MEDICINE (2013)
Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study
Shuo Wu et al.
BMC PUBLIC HEALTH (2013)
Prevalence of metabolic syndrome in Brazilian adults: a systematic review
Fernanda de Carvalho Vidigal et al.
BMC PUBLIC HEALTH (2013)
Low-density Lipoprotein Cholesterol is a Predictor of Metabolic Syndrome in a Japanese Health Screening Population
Eiji Oda
INTERNAL MEDICINE (2013)
White Blood Cell Counts as Risk Markers of Developing Metabolic Syndrome and Its Components in the Predimed Study
Nancy Babio et al.
PLOS ONE (2013)
Hematological parameters and metabolic syndrome: Findings from an occupational cohort in Ethiopia
Kelsey Nebeck et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2012)
The Metabolic Syndrome and Cardiovascular Risk A Systematic Review and Meta-Analysis
Salvatore Mottillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome
Paul Holvoet et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Multiple biomarkers and the risk of incident hypertension
Thomas J. Wang et al.
HYPERTENSION (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Increased small low-density lipoprotein particle number - A prominent feature of the metabolic syndrome in the Framingham Heart Study
S Kathiresan et al.
CIRCULATION (2006)
Increased erythropoiesis and subclinical inflammation as part of the metabolic syndrome
T Mardi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
C-reactive protein and the risk of developing hypertension
HD Sesso et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
PM Ridker
CIRCULATION (2003)
Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors
S Miyagawa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
